Related Experiment Video
Updated: Aug 19, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
[Fibrinolytic substances formation by cancer. Pathogenetic sequelae]
1Katedry i Zakładu Propedeutyki Medycyny Akademii Medycznej w Bydgoszczy.
Abstract:
A survey of literature has been presented relating to fibrinolytic substances secreted by malignant tumors, and the role of those substances in the progression of cancer. Particular attention has been given to the effects of plasmin proteolysis which is generated in the extracellular matrix by urokinase plasminogen activator (uPA) complexed with its receptor (uPAR). The paper also discusses the usefulness of the markings of the substances under discussion for diagnostic-prognostic purposes, and a perspective of using the new research in therapy, for example, by using antibodies anti-uPA and anti-uPAR.
Related Concept Videos
The Tumor Microenvironment
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Determinants of Bacterial Pathogenicity and Virulence

